lifestyle.chroniccities.us

Author: OPKO Health, Inc.

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

April 30, 2026
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

April 30, 2026
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

April 28, 2026
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

April 22, 2026
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

April 21, 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

April 8, 2026
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

February 27, 2026
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

February 26, 2026
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

February 13, 2026